Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,639,995
-
Share change
-
+534,666
-
Total reported value
-
$153,860,637
-
Price per share
-
$18.15
-
Number of holders
-
40
-
Value change
-
+$9,468,798
-
Number of buys
-
28
-
Number of sells
-
10
Institutional Holders of SIENNA BIOPHARMACEUTICALS IN - COM (SNNAQ) as of Q4 2017
As of 31 Dec 2017 SIENNA BIOPHARMACEUTICALS IN - COM (SNNAQ) had 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,639,995 shares of stock of the company.
Largest 10 holders included FMR LLC, Partner Fund Management, L.P., CLOUGH CAPITAL PARTNERS L P, Omega Fund Management, LLC, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, TimesSquare Capital Management, LLC, Partner Investment Management, L.P., Vanguard Group Inc, and MORGAN STANLEY.
This table shows 40 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.